Remdesivir and Favipiravir Antiviral Drungs Given to Some COVID-19 Patients
New Delhi:
The Supreme Court today requested a response from the Center on a plea alleging that two drugs, Remdesivir and Favipiravir, are being used for the treatment of COVID-19 without approval.
A bench led by Chief Justice SA Bobde notified the Advocacy Center and requested its response within four weeks.
Lawyer for petitioner ML Sharma in person returned the tribunal, also including Judges AS Bopanna and V Ramasubramanian, according to the World Health Organization (WHO) report of October 15 and said that nowhere are these drugs ‘were officially designated as drugs for the coronavirus.
The bench said it was only going to inform the central government and therefore issue an opinion.
On September 16, the high court said the central government had approved the use of remdesivir and favipiravir, as drugs to treat COVID-19.
The higher court was hearing a plea seeking the registration of an FIR by the CBI against ten Indian pharmaceutical companies for the manufacture and sale of these two drugs to treat COVID-19 patients allegedly without a valid license.
Remdesivir and favipiravir are antiviral drugs and their effectiveness in treating patients with COVID-19 has been the subject of debate among medical experts.
(Except for the title, this story was not edited by GalacticGaming staff and is posted from a syndicated feed.)
